...
首页> 外文期刊>Drug Metabolism and Disposition: The Biological Fate of Chemicals >Mechanistic studies on the absorption and disposition of scutellarin in humans: Selective OATP2B1-mediated hepatic uptake is a likely key determinant for its unique pharmacokinetic characteristics
【24h】

Mechanistic studies on the absorption and disposition of scutellarin in humans: Selective OATP2B1-mediated hepatic uptake is a likely key determinant for its unique pharmacokinetic characteristics

机译:人体中角cut素吸收和处置的机理研究:选择性OATP2B1介导的肝吸收可能是其独特药代动力学特征的关键决定因素

获取原文
获取原文并翻译 | 示例
           

摘要

Scutellarin [scutellarein-7-O-glucuronide (S-7-G)] displayed a unique pharmacokinetic profile in humans after oral administration: the original compound was hardly detected, whereas its isomeric metabolite isoscutellarin [scutellarein-6-O-glucuronide (S-6-G)] had a markedly high exposure. Previous rat study revealed that S-7-G and S-6-G in the blood mainly originated from their aglycone in enterocytes, and that the S-7-G/S-6-G ratio declined dramatically because of a higher hepatic elimination of S-7-G. In the present study, metabolite profiling in human excreta demonstrated that the major metabolic pathway for S-6-G and S-7-G was through further glucuronidation. To further understand the cause for the exposure difference between S-7-G and S-6-G in humans, studies were conducted to uncover mechanisms underlying their formation and elimination. In vitro metabolism study suggested that S-7-G was formed more easily but metabolized more slowly in human intestinal and hepatic microsomes. Efflux transporter study showed that S-6-G and S-7-G were good substrates of breast cancer resistance protein and multidrug resistance-associated protein (MRP) 2 and possible substrates of MRP3; however, there was no preference great enough to alter the S-7-G/S-6-G ratio in the blood. Among the major hepatic anion uptake transporters, organic anion-transporting polypeptide (OATP) 2B1 played a predominant role in the hepatic uptake of S-6-G and S-7-G and showed greater preference for S-7-G with higher affinity than S-6-G (Km values were 1.77 and 43.9 μM, respectively). Considering the low intrinsic permeability of S-6-G and S-7-G and the role of OATP2B1 in the hepatic clearance of such compounds, the selective hepatic uptake of S-7-G mediated by OATP2B1 is likely a key determinant for the much lower systemic exposure of S-7-G than S-6-G in humans.
机译:黄cut苷[scutellarein-7-O-lucuronide(S-7-G)]在人类口服后显示出独特的药代动力学特征:几乎未检测到原始化合物,而其异构代谢产物异黄酮[scutellarein-6-O-葡萄糖醛酸(S) -6-G)]的曝光量很高。先前的大鼠研究表明,血液中的S-7-G和S-6-G主要来源于肠上皮细胞中的糖苷配基,并且由于较高的肝清除率,S-7-G / S-6-G的比例急剧下降。 S-7-G。在本研究中,人类排泄物中的代谢物谱分析表明S-6-G和S-7-G的主要代谢途径是通过进一步的葡萄糖醛酸化。为了进一步了解人类中S-7-G和S-6-G的暴露差异的原因,进行了研究以揭示其形成和消除的潜在机制。体外代谢研究表明,S-7-G在人肠和肝微粒体中更容易形成,但代谢较慢。流出转运蛋白研究表明,S-6-G和S-7-G是乳腺癌抗性蛋白和多药耐药相关蛋白(MRP)2的良好底物,也是MRP3的可能底物。然而,没有足够大的偏好改变血液中的S-7-G / S-6-G比率。在主要的肝阴离子吸收转运蛋白中,有机阴离子转运多肽(OATP)2B1在肝吸收S-6-G和S-7-G中起主要作用,并且对具有较高亲和力的S-7-G表现出更大的偏爱比S-6-G高(Km值分别为1.77和43.9μM)。考虑到S-6-G和S-7-G的固有渗透率低以及OATP2B1在此类化合物的肝清除中的作用,由OATP2B1介导的S-7-G对肝的选择性摄取可能是确定这些化合物的关键因素。在人体中,S-7-G的全身暴露量远低于S-6-G。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号